...
首页> 外文期刊>Journal of gastroenterology >The role of electrogastrography and gastrointestinal hormones in chemotherapy-related dyspeptic symptoms
【24h】

The role of electrogastrography and gastrointestinal hormones in chemotherapy-related dyspeptic symptoms

机译:胃电图和胃肠激素在化疗相关的消化不良症状中的作用

获取原文
获取原文并翻译 | 示例

摘要

Background. The aim of this study was to investigate the relationship among motility disorders, dyspeptic symptoms, and plasma levels of gastrointestinal hormones in cancer patients who were well controlled for post-chemotherapy emesis. Methods. Twenty-five cancer patients treated with standard dosages of antiemetics and chemotherapies completed the study. Gastrointestinal symptoms were investigated by detailed questionnaire and visual analog score. Motility was investigated by cutaneous electrogastrography, and by blood levels of gastrin, serotonin, vasopressin, and substance P, before and 7 days after chemotherapy. Results. Before chemotherapy, no patient complained of dyspeptic symptoms, and no differences in electrogastrography (EGG) or in circulating peptide levels were found between patients who developed dyspepsia and those who did not. After chemotherapy, 13 patients suffered from dysmotility-like symptoms (total symptom score, 11.5 [2.5-37.9]; median value and 5th-95th percentiles), with susceptibility to nausea, early satiety, and postprandial fullness being the major complaints. As regards EGG parameters, a significant reduction (P = 0.04; Mann-Whitney test) in the normal slow-wave percentage and significantly increased tachygastria percentage were found in dyspeptic patients compared with symptom-free patients. The tachygastria percentage was significantly associated with susceptibility to nausea score, in a non-linear fashion (R-2 = 0.37). Dyspeptic patients showed lower levels of substance P and gastrin than patients who were not dyspeptic, but this difference had no clinical significance for dyspepsia. Conclusions. Chemotherapy may induce upper gastrointestinal symptoms suggestive of motility disorders. These dyspeptic symptoms were associated with EGG alterations, but not with variations in circulating peptides. Other hormones or pathophysiological factors, not considered in the present work, could be actively involved in these dyspeptic symptoms.
机译:背景。这项研究的目的是调查在化疗后呕吐得到良好控制的癌症患者中,运动障碍,消化不良症状和胃肠激素血浆水平之间的关系。方法。用标准剂量的止吐药和化学疗法治疗的25名癌症患者完成了该研究。通过详细的问卷调查和视觉模拟评分调查胃肠道症状。在化疗之前和之后的7天,通过皮肤电子胃动图以及胃泌素,5-羟色胺,加压素和P物质的血液水平研究了运动能力。结果。在化疗之前,没有患者抱怨消化不良症状,并且在发生消化不良的患者和没有消化不良的患者之间,胃电图(EGG)或循环肽水平没有差异。化疗后,有13例患者出现了运动障碍样症状(总症状评分11.5 [2.5-37.9];中位值和5%至95%百分数),主要症状是恶心,早饱和餐后饱胀感。关于EGG参数,与无症状患者相比,消化不良患者的正常慢波百分比显着降低(P = 0.04; Mann-Whitney测试),而胃速过百分比显着增加。心动过速百分比以非线性方式与对恶心评分的敏感性显着相关(R-2 = 0.37)。消化不良患者的P和胃泌素水平低于未消化不良的患者,但这种差异对消化不良没有临床意义。结论。化学疗法可能诱发上消化道症状,提示有运动障碍。这些消化不良症状与EGG改变有关,但与循环肽的变化无关。在本工作中未考虑的其他激素或病理生理因素可能会积极参与这些消化不良症状。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号